Based on recent clinical trials, mometasone furoate shows an efficacy and safety comparable to that of clobetasole propionate in the treatment of VLS, both in the active phase and in maintenance therapy
Lichen sclerosus (LS) is a chronic inflammatory dermatosis that mostly affects the genital and anal ...
Lichen sclerosus (LS) is a chronic disease with evidence of a lymphocyte- mediated origin. Corticos...
Lichen sclerosus (LS) is a disabling chronic inflammatory disease of skin and genital mucous membran...
Background: Twice-weekly proactive application of mometasone furoate 0.1% ointment (MMF) over 52 wee...
Background A 3-month topical application of clobetasol propionate (CP) represents the recommended a...
Background Guidelines identify a 3-month topical application of an ultra-potent corticosteroid ointm...
BACKGROUND: Topical corticosteroids are the first-line treatment for vulvar lichen sclerosus (VLS). ...
A complete clearance of vulvar lichen sclerosus (VLS) is achieved in a minority of patients treated ...
The clinical and histological response to 12 weeks of treatment with a very potent topical fluorinat...
Purpose: To assess efficacy and safety profile of combining a potent corticosteroid with a retinoid ...
The main purpose of the present study was to compare the dermoscopic changes on vulvar lichen sclero...
BACKGROUND: Vulvar Lichen Sclerosus (VLS) is a chronic inflammatory disease with a huge impact on a ...
METHODS: The authors looking for a better treatment of vulvar lichen sclerosus, treated 10 patients ...
Background: the chronic and relapsing nature of vulvar lichen sclerosus (VLS) represents a challenge...
With the aim to assess changes in both clinical and dermoscopic features of vulvar lichen sclerosus ...
Lichen sclerosus (LS) is a chronic inflammatory dermatosis that mostly affects the genital and anal ...
Lichen sclerosus (LS) is a chronic disease with evidence of a lymphocyte- mediated origin. Corticos...
Lichen sclerosus (LS) is a disabling chronic inflammatory disease of skin and genital mucous membran...
Background: Twice-weekly proactive application of mometasone furoate 0.1% ointment (MMF) over 52 wee...
Background A 3-month topical application of clobetasol propionate (CP) represents the recommended a...
Background Guidelines identify a 3-month topical application of an ultra-potent corticosteroid ointm...
BACKGROUND: Topical corticosteroids are the first-line treatment for vulvar lichen sclerosus (VLS). ...
A complete clearance of vulvar lichen sclerosus (VLS) is achieved in a minority of patients treated ...
The clinical and histological response to 12 weeks of treatment with a very potent topical fluorinat...
Purpose: To assess efficacy and safety profile of combining a potent corticosteroid with a retinoid ...
The main purpose of the present study was to compare the dermoscopic changes on vulvar lichen sclero...
BACKGROUND: Vulvar Lichen Sclerosus (VLS) is a chronic inflammatory disease with a huge impact on a ...
METHODS: The authors looking for a better treatment of vulvar lichen sclerosus, treated 10 patients ...
Background: the chronic and relapsing nature of vulvar lichen sclerosus (VLS) represents a challenge...
With the aim to assess changes in both clinical and dermoscopic features of vulvar lichen sclerosus ...
Lichen sclerosus (LS) is a chronic inflammatory dermatosis that mostly affects the genital and anal ...
Lichen sclerosus (LS) is a chronic disease with evidence of a lymphocyte- mediated origin. Corticos...
Lichen sclerosus (LS) is a disabling chronic inflammatory disease of skin and genital mucous membran...
DOI
Add to ORKG